NFKB1 and pulmonary fibrosis: Another in vitro study confirmed the anti-fibrotic properties of parthenolide through NF-κB signaling pathway suppression in primary fibroblasts derived from patients either suffering from idiopathic pulmonary fibrosis or not [121].